Trials / Conditions / Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
3 registered clinical trials studyying Relapsed or Refractory Mantle Cell Lymphoma (MCL) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lym NCT07082686 | Beijing InnoCare Pharma Tech Co., Ltd. | Phase 2 |
| Recruiting | Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT07460362 | Peking University Third Hospital | Phase 2 |
| Completed | Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell NCT00656084 | US Oncology Research | Phase 2 |